|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income attributable to common stockholders | |||||
| Adjustments to reconcile net income attributable to common stockholders to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred financing costs | |||||
| Amortization of below-market leases | |||||
| Impairment loss on real estate | |||||
| Impairment loss on goodwill | |||||
| Amortization of above- and below-market leases, net | |||||
| Amortization of fees on real estate related notes receivable | |||||
| Other amortization expenses | |||||
| Increase in current expected credit loss reserve | |||||
| Gain on dispositions of real estate | |||||
| Gain on real estate dispositions of discontinued operations | |||||
| Loss on extinguishment of debt | |||||
| Impairment losses | |||||
| Impairment and disposition losses | |||||
| Straight-line rent adjustments, net of write-offs | |||||
| Stock-based compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts payable and other liabilities | |||||
| Other assets | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Investments in real estate | |||||
| Consideration paid for the internalization transaction | |||||
| Net proceeds from real estate dispositions | |||||
| Capital expenditures and other costs | |||||
| Net payments of deposits for investments in real estate | |||||
| Fundings of real estate related notes receivable | |||||
| Fees received on real estate related notes receivable | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Payments on notes payable | |||||
| Proceeds from credit facility | |||||
| Payments for extinguishment of debt | |||||
| Payments of deferred financing costs | |||||
| Offering costs on issuance of common stock | |||||
| Distributions to common stockholders | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash - Beginning of year | |||||
| Cash, cash equivalents and restricted cash - End of year | |||||
| Supplemental cash flow disclosure: | |||||
| Interest paid, net of interest capitalized of $8, $0 and $0, respectively | |||||
| Supplemental disclosure of non-cash transactions: | |||||
| Common stock issued through distribution reinvestment plan | |||||
| Change in accrued distributions related to common stock and performance-based deferred stock unit awards | |||||
| Change in accrued capital expenditures and other costs | |||||
| Change in accrued acquisition costs related to investments in real estate | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Right-of-use assets obtained in exchange for new finance lease liabilities | |||||
Loading...